Testing Salovum for glioblastoma: oxygen and pressure
Part of Cancer clinical trials.
This trial tests if Salovum, a special egg yolk product, can improve oxygen levels and reduce pressure and inflammation in the brain for people with a suspected glioblastoma. It involves a biopsy before treatment starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected glioblastoma (a type of brain tumor)
- You are between 18 and 75 years old
- You are scheduled for a diagnostic brain biopsy
- You can and want to give informed consent (agree to join after learning the details)
- You do not have a known allergy to egg yolk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an “antisecretory factor” treatment in people with grade 4 glioblastoma (or astrocytoma). It aims to see whether it can improve outcomes when used alongside planned cancer treatments after surgery.
This trial tests whether two special food products (Salovum and SPC Flakes) can help reduce brain swelling caused by tumors. If you have a brain tumor with swelling and are already on steroids, you may be able to join.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This trial tests an oral drug called gallium maltolate for people whose glioblastoma (a type of brain cancer) has returned after standard treatment. The drug is given by mouth and may help slow tumor growth.
This study looks at how your immune system reacts to brain tumor surgery and standard treatment, using a special dye to help the surgeon see the tumor better. It aims to find out if this approach can improve outcomes for people with glioblastoma.
This trial tests an experimental immunotherapy made from your own immune cells, designed to train them to attack a protein (survivin) found in glioblastoma. It is a phase 1 study, meaning it is one of the first times this treatment is being tested in people, and it is given alongside standard radiation and chemotherapy.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.